{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:01Z","timestamp":1768435201502,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>It is rare for newly diagnosed (de novo) or newly treated acute myeloid leukemia (AML) complicated with thrombotic complications, especially combined arterial and venous thrombosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We reported a 13-year-old boy diagnosed with AML and leukocytosis, who developed right femoral vein and right dorsal artery thrombosis during chemotherapy. After treatment with low molecular weight heparin, diosmin, and alprostadil, symptoms were relieved. Unfortunately, the child suffered from coagulopathy afterward, which was unexpectedly caused by vitamin K deficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After supplementation with vitamin K and prothrombin complex concentrate, coagulation function recovered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>For childhood AML patients with high thrombotic risks, close monitoring during anticoagulant treatment was necessary. Concomitantly, we should be alert to past medication history and combined medication use, especially those that may lead to vitamin K deficiency, secondary bleeding, and coagulation disorders. Rational use of antibiotics, anticoagulants, and antitumor drugs must be guaranteed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000035121","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:08:30Z","timestamp":1697231310000},"page":"e35121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Right femoral vein and right dorsal artery thrombosis in childhood acute myeloid leukemia: A case report"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-4528","authenticated-orcid":false,"given":"Jiaqi","family":"Ni","sequence":"first","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"West China School of Pharmacy, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy\/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Su","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Department of Pediatric Hematology and Oncology, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Department of Ultrasound, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Department of Radiology, West China Second University Hospital, Sichuan University, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-589X","authenticated-orcid":false,"given":"Xiaoxi","family":"Lu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects & Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China"},{"name":"Department of Pediatric Hematology and Oncology, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.3390\/molecules27123911","article-title":"Molecular-targeted therapy of pediatric acute myeloid leukemia.","volume":"27","author":"Obsza\u0144ski","year":"2022","journal-title":"Molecules"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/cncr.26190","article-title":"AAML03P1, a pilot study of the safety of Gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia.","volume":"118","author":"Cooper","year":"2012","journal-title":"Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2007-04-084293","article-title":"Outcomes in CCG-2961, a children\u2019s oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children\u2019s oncology group.","volume":"111","author":"Lange","year":"2008","journal-title":"Blood"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2011.08851.x","article-title":"Results of a randomized trial in children with acute myeloid leukaemia: medical research council AML12 trial.","volume":"155","author":"Gibson","year":"2011","journal-title":"Br J Haematol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1200\/JCO.2010.30.6829","article-title":"Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.","volume":"29","author":"Abrahamsson","year":"2011","journal-title":"J Clin Oncol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V116.21.181.181","article-title":"Study AML-BFM 2004: Improved survival in childhood acute myeloid leukemia without increased toxicity.","volume":"116","author":"Creutzig","year":"2010","journal-title":"Blood"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1470-2045(10)70090-5","article-title":"Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.","volume":"11","author":"Rubnitz","year":"2010","journal-title":"Lancet Oncol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"101352","DOI":"10.1016\/j.beha.2022.101352","article-title":"Cancer associated thrombosis in pediatric patients.","volume":"35","author":"Barg","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl 1","key":"R9-20250504","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(20)30392-3","article-title":"Cancer-associated thrombosis in pediatric patients.","volume":"191","author":"Barg","year":"2020","journal-title":"Thromb Res"},{"issue":"Suppl 1","key":"R10-20250504","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.thromres.2018.01.019","article-title":"Thrombosis in pediatric patients with leukemia.","volume":"164","author":"Levy-Mendelovich","year":"2018","journal-title":"Thromb Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update.","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.thromres.2012.11.024","article-title":"Thrombosis in acute promyelocytic leukemia.","volume":"131","author":"Rashidi","year":"2013","journal-title":"Thromb Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/CCO.0000000000000402","article-title":"Thrombosis in adult patients with acute leukemia.","volume":"29","author":"Del Principe","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/bjh.15112","article-title":"BSH guideline: management of thrombotic and haemostatic issues in paediatric malignancy.","volume":"180","author":"Sibson","year":"2018","journal-title":"Br J Haematol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jth.15699","article-title":"Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.","volume":"20","author":"Ruiz-Llobet","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/rth2.12182","article-title":"Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis.","volume":"3","author":"Klaassen","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pbc.22432","article-title":"Bilateral internal carotid artery occlusions in a pediatric patient with refractory acute myeloid leukemia.","volume":"54","author":"Fuh","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345833","article-title":"Acute promyelocytic leukemia-associated thrombosis.","volume":"130","author":"Chang","year":"2013","journal-title":"Acta Haematol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","article-title":"Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.","volume":"101","author":"Martella","year":"2022","journal-title":"Ann Hematol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00043426-199608000-00022","article-title":"Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis.","volume":"18","author":"Murray","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"102393","DOI":"10.1016\/j.bcmd.2019.102393","article-title":"Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: comprehensive study.","volume":"81","author":"Guo","year":"2020","journal-title":"Blood Cells Mol Dis"},{"issue":"2 Suppl","key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines.","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/14740338.2020.1713090","article-title":"Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.","volume":"19","author":"Wang","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2004.04972.x","article-title":"Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.","volume":"126","author":"O\u2019Shaughnessy","year":"2004","journal-title":"Br J Haematol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jiac.2020.07.014","article-title":"Comparison of interactions between warfarin and cephalosporins with and without the N-methyl-thio-tetrazole side chain.","volume":"26","author":"Imai","year":"2020","journal-title":"J Infect Chemother"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12098-014-1584-3","article-title":"Role of prophylactic vitamin K in preventing antibiotic induced hypoprothrombinemia.","volume":"82","author":"Aziz","year":"2015","journal-title":"Indian J Pediatr"},{"key":"R28-20250504","first-page":"181","article-title":"Suspicious case of epidural hematoma due to coagulopathy caused by vitamin K deficiency associated with antibiotics.","volume":"56","author":"Hirata","year":"2007","journal-title":"Masui"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:14:44Z","timestamp":1746324884000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":27,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035121","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}